K Number
K991162
Device Name
BIOLOX ALUMINA CERAMIC FEMORAL HEAD
Date Cleared
2000-01-28

(296 days)

Product Code
Regulation Number
888.3353
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Total hip components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabiliating hips damaged as a result of trauma, inflammatory joint disease such as theumatoria arthritis, or noninflammatory degenerative joint, disease (NIDID) or any of its composite diagnoses swater disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular not disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular ne transmatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis; diastrophic ... traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the remote of the manaly inpped capital stated hip, fracture of the pelvis; diastrophic variant; remote osteomyelitis with an extended drainage free period; nonunion; femoral ne trochanteric fractures of the proximal femur with head involvement that are unmanded fracture and other techniques; femoral osteolomy, or Girdlestone resection; fracture dislocation of the high other techniques; femoral osteotomy, or Girdlestone resection; fracture disloc correction of deformity.
Device Description
The 28 mm. long Biolox Alumina Ceramic Femoral Head is manufactured from aluminum oxide (Al2O3), and it is designed for use with both titanium and cobalt chromium alloy femoral components with a 12/14 taper.
More Information

Not Found

Not Found

No
The summary describes a ceramic femoral head, a mechanical implant, and focuses on its material properties and mechanical testing. There is no mention of software, algorithms, or data processing that would suggest the use of AI/ML.

Yes
The device is a component of a total hip replacement, which is a medical intervention designed to treat conditions like trauma, inflammatory joint disease, and degenerative joint disease, thereby restoring function and alleviating symptoms. These are therapeutic objectives.

No
The device described is a total hip component (femoral head) used for surgical implantation, not for diagnosing conditions.

No

The device description clearly states it is a physical component (femoral head made of ceramic) and describes mechanical testing, indicating it is a hardware device.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly describes a surgical implant for replacing damaged hip joints. This is a therapeutic device, not a diagnostic one.
  • Device Description: The device is a physical component (femoral head) made of ceramic material, designed to be implanted in the body. IVDs are typically reagents, instruments, or systems used to examine specimens from the human body.
  • Lack of Diagnostic Function: There is no mention of this device being used to diagnose a condition, analyze a sample, or provide information about a patient's health status based on in vitro testing.
  • Performance Studies: The performance studies focus on mechanical testing and the ability of the device to withstand in vivo loading, which is relevant for an implantable device, not an IVD.

In summary, this device is a medical device (specifically, a surgical implant), but it does not fit the definition of an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

Total hip components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabiliating hips hips damaged as a result of trauma, inflammatory joint disease such as theumatoid arthritis, or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular necrosis; traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis; diastrophic variant; old, remote osteomyelitis with an extended drainage-free period; nonunion; femoral neck fracture and trochanteric fractures of the proximal femur with heads involvement that are unmanageable using other techniques; femoral osteotomy, or Girdlestone resection; fracture dislocation of the hip; and correction of deformity.

The 28 mm. long Biolox Alumina Ceramic Femoral Head is designed for single use only.

Product codes (comma separated list FDA assigned to the subject device)

87LZO/Orthopaedics

Device Description

The 28 mm. long Biolox Alumina Ceramic Femoral Head is manufactured from aluminum oxide (Al2O3), and it is designed for use with both titanium and cobalt chromium alloy femoral components with a 12/14 taper.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Hip

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Mechanical testing was performed according to the requirements in the ceramic femoral head draft guidance document. All of the test results indicate that the 28 mm. long Biolox Alumina Ceramic Femoral Head is equivalent to devices currently on the market and capable of withstanding in wivo loading without failure.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Not Found

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.

(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.

0

510(k) Summary of Safety and Effecti

28 mm. Long Biolox Alumina Ceramic Femoral Head

Submitter's name:Smith & Nephew, Inc
Submitter's address:1450 Brooks Road, Memphis, TN 38116
Submitter's telephone number:901-399-5363
Contact person:David Henley
Date summary prepared:April 01, 1999
Trade or proprietary device name:Biolox Alumina Ceramic Femoral Head
Common or unusual name:Ceramic Femoral Head
Classification name:21 CFR 888.3353 Hip joint metal/ceramic/polymer semi- constrained cemented or nonporous uncemented prosthesis Class II
Product code and panel code:87LZO/Orthopaedics
Legally marketed predicate device:Biolox Alumina Ceramic Femoral Head
-------------------------------------------------------------------------

Subject device description:

The 28 mm. long Biolox Alumina Ceramic Femoral Head is manufactured from aluminum oxide (Al2O3), and it is designed for use with both titanium and cobalt chromium alloy femoral components with a 12/14 taper.

Subject device intended use:

Total hip components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma, inflammatory joint disease such as theumatoid arthritis, or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular necrosis; traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis; diastrophic variant; old, remote osteomyelitis with an extended drainage-free period; nonunion; femoral neck fracture and trochanteric fractures of the proximal femur with heads involvement that are unmanageable using other techniques; femoral osteotomy, or Girdlestone resection; fracture dislocation of the hip; and correction of deformity.

The 28 mm. long Biolox Alumina Ceramic Femoral Head is designed for single use only.

Technological characteristics:

The 28 mm. long Biolox Alumina Ceramic Femoral Head with a 12/14 taper is similar to the devices listed below.

  • . Biolox Alumina Ceramic Femoral Head - Smith & Nephew
  • Zirconia Ceramic Femoral Head Smith & Nephew �
  • . Alumina C - Taper Ceramic Femoral Head - Osteonics

All of the devices listed above are indicated for total hip replacement and are similar in design to the 28 mm. long Biolox Alumina Ceramic Femoral Head. The new device has the same technological characteristics as the predicate device.

Performance characteristics:

Mechanical testing was performed according to the requirements in the ceramic femoral head draft guidance document. All of the test results indicate that the 28 mm. long Biolox Alumina Ceramic Femoral Head is equivalent to devices currently on the market and capable of withstanding in wivo loading without failure.

1

Image /page/1/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract image of an eagle.

Public Health Service

JAN 2 8 2000

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. David Henley Clinical/Regulatory Affairs Specialist Smith & Nephew, Inc. 1450 Brooks Road Memphis, Tennessee 38116

Re: K991162 Trade Name: Biolox Alumina Ceramic Femoral Head, 28 mm Long, 12/14 Taper Regulatory Class: II Product Code: LZO Dated: November 3, 1999 Received: November 4, 1999

Dear Mr. Henley:

Wc have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate comments of use indications for use enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). Therefore, market therefore, market the device, subject to the reasing to the Act (Act (Act). You may,
control provisions of the Act include requirements for the Act. The general control provisions of the Act include requirements for annual registrations of the Act. The general good manufacturing practice requirements for annual registration, listing of devices,
good manufacturing practice, labeling, and prohibitions against misbranding and adultera

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls) or class III
affecting your device can be found in the Code of Echnologics. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the current Good
Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodion (QS)
inspections, the Food and Drug Administration (ED) in the through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation nay result in regulation. In addition, Failure to
further announcements concerning vour dayios in the France of further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally market predicate device results in a classification for your device to a legally market
proceed to the market proceed to the market.

2

Page 2 - Mr. David Henley

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act roundation (12). Only beliefall Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597, or at initial Internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

James E. Dillard III Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

K991162

Indications Statement 28 mm. Long Biolox Alumina Ceramic Femoral Head

Total hip components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabiliating hips damaged as a result of trauma,
other treatments or devices have failed in rehabiliating hips damaged as a result inflammatory joint disease such as theumatoria arthritis, or noninflammatory degenerative joint,
disease (NIDID) or any of its composite diagnoses swater disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular not
disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular ne transmatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis; diastrophic ...
traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the remote of the manaly inpped capital stated hip, fracture of the pelvis; diastrophic variant;
remote osteomyelitis with an extended drainage free period; nonunion; femoral ne trochanteric fractures of the proximal femur with head involvement that are unmanded fracture and other techniques; femoral osteolomy, or Girdlestone resection; fracture dislocation of the high
other techniques; femoral osteotomy, or Girdlestone resection; fracture disloc correction of deformity.

Acosta

(Division Sigh-Off Division of General Restorative Device 510(k) Number

Prescription Use
(Per 21 CFR 801.109)